Changing the diabetes treatment paradigm from glucose control to cardiorenal protection

Indian J Med Res. 2021 May;154(5):655-657. doi: 10.4103/ijmr.ijmr_3114_21.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Blood Glucose
  • Cardiovascular Diseases* / drug therapy
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / prevention & control
  • Diabetes Mellitus, Type 2*
  • Humans
  • Sodium-Glucose Transporter 2 Inhibitors*

Substances

  • Blood Glucose
  • Sodium-Glucose Transporter 2 Inhibitors